Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.
Saved in:
| Title: | Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. |
|---|---|
| Authors: | Min SW; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Chen X; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Tracy TE; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Li Y; Gladstone Institute of Neurological Disease, San Francisco, California, USA., Zhou Y; Gladstone Institute of Neurological Disease, San Francisco, California, USA., Wang C; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Shirakawa K; Gladstone Institute of Virology and Immunology, San Francisco, California, USA., Minami SS; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Defensor E; Stanford Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Stanford, California, USA., Mok SA; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, California, USA., Sohn PD; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, California, USA., Schilling B; Buck Institute for Research on Aging, Novato, California, USA., Cong X; Buck Institute for Research on Aging, Novato, California, USA., Ellerby L; Buck Institute for Research on Aging, Novato, California, USA., Gibson BW; Buck Institute for Research on Aging, Novato, California, USA., Johnson J; Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA., Krogan N; Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA., Shamloo M; Stanford Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Stanford, California, USA., Gestwicki J; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, California, USA., Masliah E; Department of Neuroscience, University of California, San Diego, San Diego, California, USA., Verdin E; Gladstone Institute of Virology and Immunology, San Francisco, California, USA., Gan L; Gladstone Institute of Neurological Disease, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Nature medicine [Nat Med] 2015 Oct; Vol. 21 (10), pp. 1154-62. Date of Electronic Publication: 2015 Sep 21. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
